anti-FAP antibody (Ludwig Institute/Life Science Pharmaceuticals)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Nameanti-FAP antibody (Ludwig Institute/Life Science Pharmaceuticals)
Drug Alias Namehumanized anti-fibroblast activation protein antibody (Ludwig Institute of Cancer Research/Life Science Pharmaceuticals)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionFibroblast activation protein alpha inhibitors
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesLudwig Institute For Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLife Science PharmaceuticalsLudwig Institute For Cancer Research
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A